Log in
Forgot password ?
Become a member for free
Sign up
Sign up
Dynamic quotes 

4-Traders Homepage  >  Equities  >  OTC Bulletin Board  >  Applied DNA Sciences Inc    

News SummaryMost relevantAll newsSector news 

Applied DNA Sciences Inc : Applied DNA Sciences Continues Expansion in Sweden

share with twitter share with LinkedIn share with facebook
share via e-mail
12/11/2012 | 04:40am CEST
Applied DNA Sciences Continues Expansion in Sweden Security Giant Nokas Adopts DNA Evidentiary Marking

MEDIA CONTACT: Mitchell Miller, 646-543-3373, fax: 631-444-8848

INVESTOR CONTACT: Debbie Bailey, 631-444-8090, fax: 631-444-8848

FCMN Contact: info@adnas.com

PROGRAM CONTACT: Leif Svensson, CEO, Safe Solution AB, +46 76-774 44 14

Web site: http://www.adnas.com

Twitter: @APDN, @APDNInvestor

STONY BROOK, NY, December 10, 2012. Applied DNA Sciences, Inc. (OTC Bulletin Board: APDN), (Twitter: @APDN), a provider of DNA-based anti-counterfeiting technology and product authentication solutions, announced today that its evidentiary DNA platform has been adopted in Sweden for use in helping protect cash in transit in that country. The security company Nokas AS revealed that APDN's marking and authentication

platform will first be deployed in armored vehicles in the Stockholm area and then expanded to the company's
entire fleet.
The technology comes into play during a robbery, when botanically-based DNA marks within a water-based spray are released on cash notes and the criminals themselves. The marks can survive on the notes, clothes, and skin for long periods of time. In court, they provide accepted evidence directly linking criminals to the crime.
Nokas, based in Norway, fields a fleet of over 250 armored trucks to transport cash. It is one of only two cash transport companies in Sweden servicing many retail chains, large banks and other institutions.
The APDN platform for cash in transit already has been used with great success in the United Kingdom, where DNA evidence has helped in over fifty convictions of armed and dangerous criminals since 2009, in an environment where front-line police and private guards are typically unarmed. The DNA marking and authentication platform protects more than 26% of cash being transported to and from banks in the United Kingdom.
Johan Petersson, Nokas security officer, commented, "This is an exciting development for the entire security industry. We are the first with new technology in cash in transit in this region, which helps deter crime and helps the judiciary to prosecute any offense. Using this new technology, Nokas will provide added security to its staff and customers. We believe we are at the forefront."
Elsewhere in Sweden, adoption of the APDN DNA platform has been expanding.

share with twitter share with LinkedIn share with facebook
share via e-mail
10/14 APPLIED DNA SCIENCES INC : Change in Directors or Principal Officers, Financial ..
10/14 APPLIED DNA SCIENCES : Appoints Robert B. Catell
10/14 APPLIED DNA SCIENCES : Appoints Robert B. Catell to Its Board of Directors
10/12 APPLIED DNA SCIENCES : to Present at the 190th International Elastomer Conferenc..
10/11 APPLIED DNA SCIENCES : Expands SigNature T Cotton Tagging With Launch of Fully-A..
09/14 APPLIED DNA SCIENCES : Introduces SigNature(R) DNA Molecular Taggants to Pharmac..
09/07 APPLIED DNA SCIENCES : Expands US Cotton Tagging Business With Launch of New "Ho..
09/06 APPLIED DNA SCIENCES : Platform Stops Cotton Fiber Substitution
08/23 Applied DNA Sciences to Present at the 5th Annual Liolios Gateway Conference ..
08/11 APPLIED DNA SCIENCES : reports 3Q loss
More news
Sector news : Specialty Chemicals
10/21 After Samarco delay, BHP's 'Jac the knife' to step down
09/29 New Adidas CEO sets off in pursuit of Nike
09/29DJNew Adidas CEO Confronts 'High Bar'
09/19DJUnilever Buys 'Green' Products Maker Seventh Generation
09/07DJEuropean Firms Borrow at Subzero Rates -- WSJ
More sector news : Specialty Chemicals
Financials ($)
Sales 2016 7,53 M
EBIT 2016 -6,17 M
Net income 2016 -6,10 M
Debt 2016 -
Yield 2016 -
P/E ratio 2016 -
P/E ratio 2017
Capi. / Sales 2016 9,12x
Capi. / Sales 2017 3,75x
Capitalization 68,6 M
More Financials
Income Statement Evolution
More Financials
Mean consensus OUTPERFORM
Number of Analysts 1
Average target price 8,00 $
Spread / Average Target 181%
Consensus details
EPS Revisions
More Estimates Revisions
James A. Hayward Chairman, President & Chief Executive Officer
Beth Jantzen Chief Financial Officer
Ming-Hwa Benjamin Liang Secretary & Chief Scientific Officer
Judith Murrah Chief Information Officer
Sanford R. Simon Independent Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
SIKA AG24.28%9 593
SYMRISE AG0.72%8 742
CLARIANT AG-10.99%5 553
More Results